Resources

Search

Menu

Close

Resources

Contact us

Manufacturing services

Oral solid dose

Sterile injectables

Antibody-drug conjugates

Tech transfer

Manufacturing network

OSD manufacturing

SI manufacturing

ADC manufacturing

About us

Careers

Leadership team

Regulatory support

Sustainability

IP protection

Expert insights

Antibody-drug conjugates

Stand at the forefront of ADC innovation

As a global CMO powered by Pfizer, we leverage over two decades of antibody-drug conjugate (ADC) innovation. Backed by a world-class manufacturing facility in Pearl River, NY, we are ready to help you get your therapy to commercialization at speed to answer patients’ needs.

We harness a strong track record of ADC success, including producing the world’s first commercially approved ADC product (MylotargTM), to drive advancement and help us achieve better ADC solutions together.

Speak to our ADC experts today

Loading

Why choose Pfizer CentreOne for your ADC?

Leaders in ADC manufacturing with a legacy of success.

 

For over 20 years, Pfizer’s global experts have been at the forefront of ADC innovation, giving us an unparalleled understanding of the complexities involved in bringing these life-changing therapies to market.

 

Pfizer's experience producing the world's first commercially approved ADC (Mylotarg™) provides the foundation for our comprehensive solutions and unwavering commitment to your success.

An all-in-one ADC powerhouse.

 

Providing dedicated space for highly potent and cytotoxic drug processing, Pearl River, Pfizer’s specialized facility, is designed for the safe and efficient manufacturing of complex ADC.

 

We offer fully integrated capabilities, encompassing cytotoxic compounds, drug substance intermediates, specialized cytotoxic payloads, linkers, and final ADC assembly—all under one roof.

Quality and reliability in every ADC we deliver.

 

Our robust, meticulously optimized processes deliver consistent high quality and accelerate timelines, bringing your ADC therapy to patients faster.

 

Real-time data sharing and robust communication protocols keep you fully informed throughout the ADC production process, ensuring complete transparency and trust.

Expert content

WHITEPAPER

Unravel the complexities of ADC manufacturing in our whitepaper

 

Download whitepaper

Loading

View all

Loading

SITE SPOTLIGHT

Find out how Pfizer’s state-of-the-art Pearl River, NY, facility can support your ADC journey  

Download the site spotlight

Loading

View all

Loading

Our ADC manufacturing network

In ADC manufacturing, unraveling complexities is key because time is life.

 

As an experienced global CMO partner, powered by Pfizer, we can help you skillfully maneuver ADC challenges, keeping pace with scientific advancements and regulatory requirements to bring your critical therapy to patients.

Discover our ADC manufacturing network

Loading

Meet our antibody drug conjugate experts

Dave Merkooloff

Technical Services Site Lead | Pearl River, NY, USA


Responsible for technical transfer and validation of ADCs and immunoconjugates, Dave has over 20 years of experience in commercial and clinical manufacturing to support you throughout your journey.   

Ready to embark on your ADC journey?

Contact our experts to start your manufacturing journey.

Contact us

Loading
Loading

Success

Thank you, your submission has been received!

A CMO for therapies that define legacies

Follow us

Latest marketing updates 

Sign up

Loading

© 2025 Pfizer Inc. All rights reserved. Pfizer CentreOne is a registered trademark of Pfizer Inc. Privacy Policy | Terms of Use